On the Absoluteness of ℵ1-Freeness von Herden, D., Pasi, A. V.

Volltext

Lifetime measurement in picoseconds for the excited states of 129Cs von Lamani, Umakant, Das, Pragya, Bhujang, B., Pasi, V.

Volltext

Inconsistent Results With Different Secondary Reflex Assays for Resolving HER2 Status von Willmore-Payne, Carlynn, Damjanovich-Colmenares, Kristy, Pasi, Alexandra V., Werner, Theresa L., Gulbahce, H. Evin, Downs-Kelly, Erinn, Geiersbach, Katherine B.

Volltext

Projecting Spirits: Speculation, Providence, and Early Modern Optical Media von Valiaho, Pasi

Volltext

Genomic Copy Number Analysis of HER2-Equivocal Breast Cancers von Geiersbach, Katherine B., Willmore-Payne, Carlynn, Pasi, Alexandra V., Paxton, Christian N., Werner, Theresa L., Xu, Xinjie, Wittwer, Carl T., Gulbahce, H. Evin, Downs-Kelly, Erinn

Volltext

Forcing a basis into ℵ1-free groups von Bossaller, Daniel, Herden, Daniel, Pasi, Alexandra V.

Volltext

On the Absoluteness of âµ.sub.1-Freeness von Herden, D, Pasi, A. V

Volltext

On the absoluteness of $\aleph_1$-freeness von Herden, Daniel, Pasi, Alexandra V

Volltext bestellen

Forcing a Basis into $\aleph_1$-Free Groups von Bossaller, Daniel, Herden, Daniel, Pasi, Alexandra V

Volltext bestellen

On the absoluteness of \(\aleph_1\)-freeness von Herden, Daniel, Pasi, Alexandra V

Volltext

Forcing a Basis into \(\aleph_1\)-Free Groups von Bossaller, Daniel, Herden, Daniel, Pasi, Alexandra V

Volltext

Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component von Yang, James Chih-Hsin, Ahn, Myung-Ju, Kim, Dong-Wan, Ramalingam, Suresh S, Sequist, Lecia V, Su, Wu-Chou, Kim, Sang-We, Kim, Joo-Hang, Planchard, David, Felip, Enriqueta, Blackhall, Fiona, Haggstrom, Daniel, Yoh, Kiyotaka, Novello, Silvia, Gold, Kathryn, Hirashima, Tomonori, Lin, Chia-Chi, Mann, Helen, Cantarini, Mireille, Ghiorghiu, Serban, Jänne, Pasi A

Volltext

PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib von ENGELMAN, Jeffrey A, ZEJNULLAHU, Kreshnik, ALTHAUS, Irene W, GANDHI, Leena, SHAPIRO, Geoffrey I, NELSON, James M, HEYMACH, John V, MEYERSON, Matthew, WONG, Kwok-Kin, JÄNNE, Pasi A, GALE, Christopher-Michael, LIFSHITS, Eugene, GONZALES, Andrea J, SHIMAMURA, Takeshi, FENG ZHAO, VINCENT, Patrick W, NAUMOV, George N, BRADNER, James E

Volltext

Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy von Pasi, K. John, Rangarajan, Savita, Georgiev, Pencho, Mant, Tim, Creagh, Michael D, Lissitchkov, Toshko, Bevan, David, Austin, Steve, Hay, Charles R, Hegemann, Inga, Kazmi, Rashid, Chowdary, Pratima, Gercheva-Kyuchukova, Liana, Mamonov, Vasily, Timofeeva, Margarita, Soh, Chang-Heok, Garg, Pushkal, Vaishnaw, Akshay, Akinc, Akin, Sørensen, Benny, Ragni, Margaret V

Volltext

Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C Mutation von Jänne, Pasi A., Riely, Gregory J., Gadgeel, Shirish M., Heist, Rebecca S., Ou, Sai-Hong I., Pacheco, Jose M., Johnson, Melissa L., Sabari, Joshua K., Leventakos, Konstantinos, Yau, Edwin, Bazhenova, Lyudmila, Negrao, Marcelo V., Pennell, Nathan A., Zhang, Jun, Anderes, Kenna, Der-Torossian, Hirak, Kheoh, Thian, Velastegui, Karen, Yan, Xiaohong, Christensen, James G., Chao, Richard C., Spira, Alexander I.

Volltext

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer von Vaishnavi, Aria, Capelletti, Marzia, Le, Anh T, Kako, Severine, Butaney, Mohit, Ercan, Dalia, Mahale, Sakshi, Davies, Kurtis D, Aisner, Dara L, Pilling, Amanda B, Berge, Eamon M, Kim, Jhingook, Sasaki, Hidefumi, Park, Seung-il, Kryukov, Gregory, Garraway, Levi A, Hammerman, Peter S, Haas, Julia, Andrews, Steven W, Lipson, Doron, Stephens, Philip J, Miller, Vince A, Varella-Garcia, Marileila, Jänne, Pasi A, Doebele, Robert C

Volltext

First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic EGFR Mutations von SEQUIST, Lecia V, MARTINS, Renato G, KUHLMANN, Georgiana L, HAN, Moon, GOLDBERG, Jonathan S, SETTLEMAN, Jeffrey, IAFRATE, A. John, ENGELMAN, Jeffrey A, HABER, Daniel A, JOHNSON, Bruce E, LYNCH, Thomas J, SPIGEL, David, GRUNBERG, Steven M, SPIRA, Alexander, JDNNE, Pasi A, JOSHI, Victoria A, MCCOLLUM, David, EVANS, Tracey L, MUZIKANSKY, Alona

Volltext

Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer von Nardi, Francesca, Perurena, Naiara, Schade, Amy E, Li, Ze-Hua, Ngo, Kenneth, Ivanova, Elena V, Saldanha, Aisha, Li, Chendi, Gokhale, Prafulla C, Hata, Aaron N, Barbie, David A, Paweletz, Cloud P, Jänne, Pasi A, Cichowski, Karen

Volltext

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A von Ozelo, Margareth C, Mahlangu, Johnny, Pasi, K. John, Giermasz, Adam, Leavitt, Andrew D, Laffan, Michael, Symington, Emily, Quon, Doris V, Wang, Jiaan-Der, Peerlinck, Kathelijne, Pipe, Steven W, Madan, Bella, Key, Nigel S, Pierce, Glenn F, O’Mahony, Brian, Kaczmarek, Radoslaw, Henshaw, Joshua, Lawal, Adebayo, Jayaram, Kala, Huang, Mei, Yang, Xinqun, Wong, Wing Y, Kim, Benjamin

Volltext

Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses von Sundaresan, Tilak K, Sequist, Lecia V, Heymach, John V, Riely, Gregory J, Jänne, Pasi A, Koch, Walter H, Sullivan, James P, Fox, Douglas B, Maher, Robert, Muzikansky, Alona, Webb, Andrew, Tran, Hai T, Giri, Uma, Fleisher, Martin, Yu, Helena A, Wei, Wen, Johnson, Bruce E, Barber, Thomas A, Walsh, John R, Engelman, Jeffrey A, Stott, Shannon L, Kapur, Ravi, Maheswaran, Shyamala, Toner, Mehmet, Haber, Daniel A

Volltext